Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Hits New 1-Year High – Here’s Why

Bayer Aktiengesellschaft (OTCMKTS:BAYRY)’s share price reached a new 52-week high on Wednesday. The stock traded as high as $15.24 and last traded at $15.2270, with a volume of 978,158 shares traded. The stock had previously closed at $14.41.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of Bayer Aktiengesellschaft from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 10th. Two equities research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy”.

Bayer Aktiengesellschaft Stock Down 1.2%

The firm has a market capitalization of $60.25 billion, a price-to-earnings ratio of -33.33, a P/E/G ratio of 1.90 and a beta of 0.57. The firm has a fifty day moving average price of $13.47 and a 200 day moving average price of $12.59. The company has a current ratio of 1.04, a quick ratio of 0.67 and a debt-to-equity ratio of 1.05.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last posted its quarterly earnings data on Tuesday, November 3rd. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by ($0.02). Bayer Aktiengesellschaft had a positive return on equity of 16.34% and a negative net margin of 3.28%. The firm had revenue of $11.25 billion for the quarter, compared to analyst estimates of $11.21 billion. Sell-side analysts anticipate that Bayer Aktiengesellschaft will post 1.29 EPS for the current fiscal year.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft is a German life sciences company headquartered in Leverkusen. Founded in 1863, it develops products and services in pharmaceuticals, consumer health and agriculture.

Its Pharmaceuticals business offers prescription medicines, including treatments in areas such as cardiovascular disease, oncology, women’s health and eye care. Consumer Health sells nonprescription medicines and self-care products, with brands including Claritin, Aleve and One A Day.

Through its Crop Science business, Bayer provides seeds, crop protection products and agricultural solutions for farmers.